Moradi Jale, Moradi Parnia, Alvandi Amir H, Abiri Ramin, Moghoofei Mohsen
Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Future Virol. 2022 Oct. doi: 10.2217/fvl-2021-0056. Epub 2022 Oct 22.
SARS-CoV-2 is an emerging coronavirus that was discovered in China and rapidly spread throughout the world. The authors looked at nucleotide and amino acid variations in SARS-CoV-2 genomes, as well as phylogenetic and evolutionary events in viral genomes, in Iran. All SARS-CoV-2 sequences that were publicly released between the start of the pandemic and 15 October 2021 were included. The majority of mutations were found in vaccine target proteins, Spike and Nucleocapsid proteins, and nonstructural proteins. The majority of the viruses that circulated in the early stages of the pandemic belonged to the B.4 lineage. We discovered the prevalence of viral populations in Iran. As a result, tracking the virus's variation in Iran and comparing it with a variety of nearby neighborhoods may reveal a pattern for future variant introductions.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新出现的冠状病毒,在中国被发现并迅速传播至全球。作者研究了伊朗SARS-CoV-2基因组中的核苷酸和氨基酸变异,以及病毒基因组中的系统发育和进化事件。纳入了疫情开始至2021年10月15日期间公开发布的所有SARS-CoV-2序列。大多数突变出现在疫苗靶蛋白、刺突蛋白和核衣壳蛋白以及非结构蛋白中。疫情早期传播的大多数病毒属于B.4谱系。我们发现了伊朗病毒群体的流行情况。因此,追踪伊朗病毒的变异并与周边不同地区进行比较,可能会揭示未来变异毒株引入的模式。